The growing demand for controlled immunological investigation and therapeutic design has spurred significant improvements in recombinant signal molecule generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently generated using multiple expression platforms, including bacterial hosts, animal cell lines, and ba